Litcius/Paper detail

Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial

Jieyun Xia, Qian Sun, Dian Zhou, Hujun Li, Ying Wang, Yuekun Qi, Jiang Cao, Zhiling Yan, Depeng Li, Hai Cheng, Wei Sang, Feng Zhu, Haiying Sun, Wei Chen, Kunming Qi, Dongmei Yan, Tingting Qiu, Tingyu Hu, Weiying Gu, Jun Qian, Fan Xia, Na Qi, Congqian Jin, Yang Liu, Xue Wang, Yanlei Zhang, Shuixiu Peng, Zhenyu Li, Alex H. Chang, Kailin Xu

2025The Lancet Haematology21 citationsDOI

Topics & Concepts

MedicineMultiple myelomaCAR T-cell therapySalvage therapyOncologyCell therapyInternal medicineSurgeryCellChimeric antigen receptorImmunotherapyChemotherapyCancerGeneticsBiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsCutaneous lymphoproliferative disorders research